(Total Views: 244)
Posted On: 04/03/2021 1:11:21 AM
Post# of 653

$RLFTF (related) NeuroRx NeuroRxPharma · 8h Listen to our 3/29 investor call on ZYESAMI™ demonstrating significant benefit in critical #COVID19 survival and meeting the primary endpoint of phase 2b/3 clinical trial:
https://bit.ly/3dt7MOP
aviptadil ZYESAMI
https://bit.ly/3dt7MOP
aviptadil ZYESAMI


$MJ